The practice of quarantine or isolation, as we know it, began during the 14th century in an effort to protect coastal cities from plague epidemics. Ships arriving in Venice from infected ports were required to anchor on the nearby island of Lazzaretto Nuovo for 40 days before landing. How appropriate then that an international consultation on prevention and control of health-care-associated infections (HAIs) took place in Venice recently (April 26--28, 2004).

The WHO assembled experts from eastern and central Europe for the first time. The aim was to discuss issues of HAI prevention and control across these countries, identify essential areas WHO should address in its future interventions, and begin a working strategy for countries on HAI surveillance, prevention, and control. What was unique was that each country brought with them a health manager (eg, local government representative, or hospital administrator), a health professional involved in infection control activities, and a high-level policy maker, in recognition of the fact that HAIs require teamwork.

In the UK preventable HAIs are responsible for more than 500 deaths per year, with an economic burden of £1 billion per year. WHO\'s activities in this area have been limited and somewhat fragmented. They currently have no established group or strategy to tackle HAIs, regionally or at a global level. But recent events have changed their thinking. Last year severe acute respiratory syndrome (SARS) spread through hospitals with 21% of cases occurring in health-care workers. The basics of infection control were not respected, and the disease quickly spread from the hospital to the community. HAIs\' close link with antimicrobial resistance, and the role of nosocomial transmission in fuelling outbreaks like SARS, has now meant that HAIs should no longer be considered an individual hospital problem, but a more general public-health one.

Addressing HAIs in Europe is a challenge. Variations in health spending across Europe are huge, so finding common denominators in hetereogenous hospital-settings is difficult. Furthermore, the exclusion of health care from the mandate of the European Commission (EC) means that the EC cannot insist member states comply with proposals and recommendations on HAIs. This means that there is no driving force at community level to harmonise member states in this area.

Participating countries in the meeting included Lithuania, Bulgaria, Ukraine, Romania, Turkey, Croatia, Kyrgyzstan, Russia, and Poland. Historically, infection control measures and policies have been poor in some of these countries, and even the true incidence of HAIs is still unknown due to under-reporting and lack of funds and resources. But what was encouraging to hear was how much some of these countries have achieved recently in terms of conducting surveillance and national prevalence studies, monitoring antimicrobial usage and resistance, and developing components towards establishing a national infection control programme. Countries were motivated to build on their foundations with the help from WHO and the EC.

In terms of a HAI strategy there is no doubt that a multidisciplinary approach will be required. Strengthening country\'s microbiological and clinical capacities, raising the profile of infection control in hospitals, partnering existing European networks and professional bodies, hospital accreditation, and cost-effectiveness and cost-benefit analysis were just some of the areas that will need addressing. Initially, a minimum set of indicators and standards will need to be agreed upon. Then whatever actions are taken need to be sustainable. An important point is for health-care workers to take ownership or responsibility for infection control, and for this concept to be introduced into the curriculum of future generations of HCWs---ie, a cultural and behavioural change is required. The strategy should also put antimicrobial resistance (see p 325) in the context of HAIs. By tackling antimicrobial resistance in the hospital setting and following it up with effective infection control measures, we will reduce community spread of resistant organisms. What we must not have, however, is a strategy without implementation. Since its publication in 2001, there has been no implementation of the WHO Global Strategy for Containment of Antimicrobial Resistance. It is important to learn from these experiences.

Today, hospitals are not the safe places they once were. We should not forget the enormous costs to the patient, their families, and the societal costs of HAIs. Infection control saves lives and money so there is much to be gained to control and prevent HAIs in Europe.
